COVID-19 Reagent Portfolio

About Immune Technology Corp

Immune Technology Corp is a private, early-revenue stage biotechnology company operating as a reagent and contract service provider in the immunology and infectious disease sectors. The company leverages a platform for producing high-quality viral antigens and antibodies to support global research efforts against pathogens like SARS-CoV-2, influenza, and Zika virus. Its business model combines the sale of catalog research products with custom service offerings, including protein production and antibody development. While not a therapeutic developer, IT positions itself as a critical enabler for diagnostic, vaccine, and therapeutic research within the virology field.

Therapeutic Areas